Morgan Stanley’s Structure Therapeutics GPCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Buy |
917,346
+224,907
| +32% | +$4.66M | ﹤0.01% | 2860 |
|
|
2025
Q1 | $12M | Buy |
692,439
+305,263
| +79% | +$5.28M | ﹤0.01% | 3179 |
|
|
2024
Q4 | $10.5M | Buy |
387,176
+224,690
| +138% | +$6.09M | ﹤0.01% | 3368 |
|
|
2024
Q3 | $7.13M | Buy |
162,486
+30,195
| +23% | +$1.33M | ﹤0.01% | 3681 |
|
|
2024
Q2 | $5.2M | Sell |
132,291
-161,342
| -55% | -$6.34M | ﹤0.01% | 3837 |
|
|
2024
Q1 | $12.6M | Sell |
293,633
-280,505
| -49% | -$12M | ﹤0.01% | 3154 |
|
|
2023
Q4 | $23.4M | Buy |
574,138
+550,324
| +2,311% | +$22.4M | ﹤0.01% | 3199 |
|
|
2023
Q3 | $1.2M | Buy |
+23,814
| New | +$1.2M | ﹤0.01% | 4691 |
|
|
2023
Q2 | – | Sell |
-11
| Closed | -$262 | – | 7678 |
|
|
2023
Q1 | $262 | Buy |
+11
| New | +$262 | ﹤0.01% | 7499 |
|